Meet MiniMed

Making every day a better day for people with diabetes.

Learn more
360 motion MiniMed product portfolio
Woman holding phone, Woman holding phone,

It’s called MiniMedTM 780G and it has improved my quality of life tremendously.

Nicole

MiniMedTM 780G system user

Our Insulin management solutions

Insulin Pump Therapy

Self-adjusting insulin pump

The MiniMedTM 780G system is a fully integrated system that automatically adjusts insulin delivery to your needs day and night.1,2

96%

Fewer injections compared to MDI#
80%

Helps to reach 80% Time in range3

Discover more

Multiple Daily Injection Therapies

What is a Smart MDI System?

The Smart MDI system combines the power of our latest innovation in continuous glucose monitoring (CGM), GuardianTM 4 Smart  CGM system with the InPenTM Smart  Insulin Pen System.

Discover more

Discover WeCare

WeCare - here for your diabetes journey

We are always here to support you, offering personalised onboarding programs and 24/7 hour support. We also have a mobile app to help make life easier for you.

Learn more

About us

MiniMed is the complete insulin delivery company. Built around one belief: that technology should ease the burden of diabetes. So that every day is a better day.

Days when diabetes fades into the background and life takes the lead. Joyful, messy, fully lived days — when things feel lighter, easier, more possible. Those are the days we’re here to make real.

Need support?

|

You can contact us here

Go to the Contact page
References
  1. Medtronic data on file. Pivotal Trial (Age 14-75). N=157. 2020; 16 US sites
  2. Based on the recommended MiniMedTM MioTM Advance and MiniMedTM Quick-setTM insulin infusion set change every 2-3 days compared to 4 injections a day for 30 days
  3. Medtronic data on file: MiniMedTM 780G data uploaded voluntarily by 12.870 users in EMEA to CareLinkTM Personal, from 27 August 2020 to 22 July 2021. Mean 80% TIR reached by 1.784 users using MiniMedTM 780G with recommended settings of 2 hours active insulin time and 100 mg/dL (5.5 mmol/L) as glucose target for at least 90% of the time.